107
Participants
Start Date
December 23, 2013
Primary Completion Date
February 15, 2015
Study Completion Date
February 15, 2015
Fluticasone propionate
All subjects receive FP 0.05% cream twice daily up to 4 weeks to all affected sites and any newly occurring sites in ACUTE phase. After randomization in MAINTENANCE phase, subjects either receive emollient (Physiogel) twice daily extendedly plus FP 0.05% cream once daily twice a week to all healed sites and any newly occurring sites (Group A), or emollient (Physiogel) twice daily extendedly (Group B), up to 20 weeks. In FOLLOW-UP phase, all subjects apply emollient (Physiogel) twice daily up to 12 weeks.
GSK Investigational Site, Shanghai
GSK Investigational Site, Changsha
GSK Investigational Site, Shenzhen
GSK Investigational Site, Beijing
Lead Sponsor
GlaxoSmithKline
INDUSTRY